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Abstract Domains present one of the most useful levels at
which to understand protein function, and domain family-based
analysis has had a profound impact on the study of individual
proteins. Protein domain discovery has been progressing steadily
over the past 30 years. What are the realistically achievable goals
of sequence-based domain analysis, and how far off are they for
the sequences encoded in eukaryotic genomes? Here we address
some of the issues involved in better coverage of sequence-based
domain annotation, and the integration of these results within the
wider context of genomes, structures and function. ß 2002
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Genome sequences may be large, but they are ¢nite. In
1992, Chothia showed that when homology between genes is
taken into account by comparison of protein sequence and
structure, the overall number of distinct protein families (i.e.
folds) is likely to be surprisingly small : a thousand or so, an
order of magnitude smaller than the number of genes in a
genome [1]. Subsequent work has led to di¡ering estimates
(for a recent approach, see e.g. [2]), but the impact of the
essential message remains. Now that complete genome se-
quences are available, we should, within certain limits, be
able to delineate all the protein domains that are contained
within them. What progress is being made in the journey
towards this goal?
The term ‘domain’ can relate to protein structure or func-
tion, but our interest here is in the former sense. Domains are
regions of compact protein structure, typically with a hydro-
phobic core [3]. Beyond this, it is useful to distinguish the
term ‘domain family’ from ‘protein family’. The former im-
plies the discrete structural folding unit, whereas the latter
refers to a combination of domains that always occur together
within the same polypeptide, or to proteins composed of a
single domain.
Domains themselves may have evolved from smaller struc-
tural units such as repeats [4] or the assembly of small folding
motifs into larger structures seen today [5]. There is evidence
to suggest that genetically mobile elements like transposable
elements may also in£uence protein structure, e.g. [6]. Even
so, whole domains do seem to be the dominant structural unit
shaping proteins, and in addition, correlation with experimen-
tal results suggests they often represent fundamental function-
al units. Sequence-based domain de¢nitions are, therefore,
one of the most convenient and practically important levels
at which to understand the evolution of protein function.
Domain types that are found with di¡erent combinations of
domains in di¡erent proteins are particularly signi¢cant. Ho-
mologous sequence is assumed to have similar function, what-
ever the context, so these ‘modules’ or ‘mobile domains’ allow
the transfer of functional information, such as being involved
in a particular kind of interaction, between distinct protein
classes. The exact extent to which functional information
can be usefully transferred, however, varies greatly and may
be di⁄cult to establish a priori, although the higher the pro-
portion of shared domains in two proteins, the more similar
their functions [7].
Breaking a protein down into its constituent domain com-
ponents is evidently a reductionist approach, but one which,
to judge from the level of citations of domain discovery pa-
pers (see Fig. 1), is of great importance to an understanding of
protein function. This is particularly true of metazoan ge-
nomes, and human in particular, where multi-domain proteins
abound [8]. The identi¢cation of orthologues (genes related by
speciation events) and paralogues (genes related by an intra-
genome duplication event) represents an alternative and com-
plementary approach to tracking the evolution of function,
but the many-to-many evolutionary relationships of metazoan
proteins, and their multi-domain nature, complicates the ap-
plication of these concepts, making initial domain-based an-
notation more appealing [9]. Thus, increasing the numbers of
proteins for which domain-based annotation can be provided
is an important goal of computational genome analysis.
2. Improvements in sequence database searching
The domain is de¢ned in terms of protein structure, but as
protein sequence determines protein structure, and sequence
data is much easier (and cheaper) to come by than structural
data, much discovery of mobile protein domain families has
revolved around the identi¢cation of conserved sequences.
This means that improvements in sequence database-searching
techniques will directly lead to better coverage of protein do-
mains.
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Techniques for searching sequence databases and determin-
ing whether the similarity between two sequences is likely to
be due to homology are well established [10], and we have
previously described their application to domain discovery
[11]. Subtle improvements continue to be made, in particular
to the statistical models used to determine signi¢cance levels
in sequence comparison; new methods have been imple-
mented to better model the e¡ects of biased residue composi-
tion of sequences [12,13]. These incremental improvements in
speci¢city (the ability to discriminate between true and false
positives) can occasionally lead to more radical improvements
in sensitivity, as the correct identi¢cation of borderline
matches can provide crucial bridges between distinct subfam-
ilies of a given sequence family.
The past 3 decades have seen relatively steady levels of
domain discovery (Fig. 2). Although it seems likely that
most of the more common mobile protein domains have al-
ready been described in the literature, the ever-increasing
numbers of sequences in databases provide new sources for
domain detection. The value of new sequences comes from
two e¡ects. Firstly, they can provide new contextual informa-
tion for particular regions of homology, making it obvious
that a particular homologous sequence family constitutes a
mobile module. Secondly, new sequences can lead to the for-
mation of statistically signi¢cant bridges between two families
that had not previously appeared to be mobile. Additional
sequences in a database also reduce the statistical signi¢cance
of true matches when database searching [14]. In practice, the
former two e¡ects appear to more than compensate for this
latter phenomenon, so new distant sequence relationships con-
tinue to be discovered despite growing database sizes.
3. Automatic approaches to domain detection
It is computationally intensive, but relatively straightfor-
ward, to apply database-searching techniques to entire se-
quence databases (for instance, either a whole genome, or a
complete non-redundant sequence database), and thus estab-
lish all signi¢cant sequence similarities detectable by any given
method. These similarities between pairs of sequences can
then be clustered into sets of putatively homologous proteins.
However, the multi-domain nature of proteins complicates the
Fig. 1. Plot of total numbers of citations for selected domains (SH2, SH3, PH, CH, BROMO, WW, DH, FHA, PTB, PDZ, WH2, FYVE, EH,
VHS, ENTH). The number of citations for 2001 is an estimate ^ 1/6 of the current numbers for 2001 (i.e. approximately 2 months) were added
to provide an approximation to the total for the year. Only articles mentioning the domain names in the title or the abstract were counted.
Fig. 2. Plot of cumulative numbers of detected domains or solved structures against year. Bold blue line: number of detected extracellular do-
mains, bold green line: number of detected nuclear domains, bold orange line: number of detected signalling domains, thin blue line: number
of solved extracellular domain structures, thin green line: number of solved nuclear domain structures, thin orange line: number of solved sig-
nalling domain structures.
FEBS 25670 21-2-02 Cyaan Magenta Geel Zwart
R.R. Copley et al./FEBS Letters 513 (2002) 129^134130
clustering procedure. A protein consisting of two domains, A
and B, will cause the cluster containing homologs of domain
A to be merged with that containing homologs of domain B.
A number of automatic techniques have been developed to
identify multi-domain proteins and decompose them into their
respective domain complements [15^20]; the basic principle of
all is that domain boundaries can be inferred by automatic
inspection of sequence alignments. In practice, low levels of
sequence conservation between members of a domain family
can make it di⁄cult to establish domain boundaries, partic-
ularly from sets of pairwise sequence comparisons. This, and
other problems, such as the di⁄culty of setting universal
thresholds to establish homology between sequences within
domain families, and the problem of usefully annotating au-
tomatically de¢ned families, reduce the e⁄cacy of these oth-
erwise attractive approaches.
4. Domain databases
Databases such as SMART (http://smart.embl-heidel-
berg.de), concentrating chie£y on mobile domains [21], and
PFAM (http://www.sanger.ac.uk/software/pfam/), which cov-
ers protein families and domains [22], make use of hand-
edited sequence alignments representing single protein do-
mains. An initial set of homologs is gathered, usually via a
database search, although other techniques, such as internal
repeat detection can be more e⁄cient [12,43]. The sequences
are then automatically aligned and the alignment manually
edited to improve quality. This alignment can then be used
to perform another search against the sequence database via a
pro¢le or hidden Markov model. This process can then be
iterated until no new hits are found. Once completed, the
model has statistical thresholds associated with it to ensure
the correct classi¢cation of true and false positive sequence
matches. These thresholds are decided by the annotator pre-
paring the speci¢c model, and are not universally applied to
all the models in a database.
Various web-based resources exist for searching libraries of
the domain models constructed in this way, and thus identi-
fying known domains in protein sequences (see Fig. 3 for an
example of SMART output). In addition to the search sites of
the databases themselves, ‘meta’-sites exist that allow for the
searching of multiple domain databases. For instance, the
Interpro database, at the EBI (http://www.ebi.ac.uk/interpro/)
allows the searching of the Prosite, PFAM, PRINTS, Pro-
Dom and SMART model collections [23], and the Conserved
Domain Database (CDD) at the NCBI (http://www.ncbi.
nlm.nih.gov/structure/cdd/cdd.shtml) allows the searching of
pro¢les derived from SMART and PFAM using a modi¢ed
version of the Blast algorithm.
5. Increasing coverage: using domain databases as tools in the
discovery of new domains
Automatic clustering procedures can be combined with cu-
rated domain databases to facilitate the detection of novel
domains. Sequence libraries can ¢rst be screened for known
domains from libraries such as SMART or PFAM. Any se-
Fig. 3. Domain architectures of proteins containing the BRK domain. The domain is predicted to have a nuclear localization based on co-oc-
currence with other domains found in nuclear proteins. Only proteins with distinct modular organizations are shown. The domain names are
according to the SMART database (http://smart.embl-heidelberg.de). First architecture: Kismet-like protein KIAA1416 (Acc. Nr. Q9P2D1),
second architecture: BRM-like protein BRM (Acc. Nr. P51531), third architecture: TFS2M-domain containing protein CG6525 (Acc. Nr.
Q9VG78)
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quence or region of sequence that does not fall into one of
these domain families can then be subjected to automatic
homology searching and domain clustering procedures. The
ProDom database, for instance, uses the manually curated
sequence families contained in PFAM as seeds, and in turn
automatically generated ProDom families are used within
PFAM, as a source both of additional annotation, and ulti-
mately, new hand-curated models [22,24]. A necessity of such
an approach is that close to the full length of known domains
is modelled in the curated database (i.e. the database does not
simply model a conserved motif within the domain), such that
the regions subjected to automatic clustering are distinct from
the known domains.
Excluding known protein domains reduces the size of the
sequence database that needs to be searched when hunting for
new domains, which can serve to highlight hits that were
previously of marginal signi¢cance. At the same time, if the
sequence database searched is cross-referenced to known do-
mains, it is an easier job to identify regions of sequence that
are found within di¡erent domain contexts. We have recently
used such a strategy to search systematically for novel do-
mains associated with nuclear functions leading to the identi-
¢cation of 28 new domains [44]. Although it is possible to
automate large parts of the domain detection procedure,
and produce a list of candidate domains, large amounts of
manual work are involved in distilling useful biological
knowledge from the literature, and producing high quality
sequence alignments. In particular, automatically identifying
distinct domain contexts for homologous regions of sequence
(a necessity for the detection of mobile domains) is hampered
by problems such as failure to identify all instances of known
domains in the source database and erroneous fusions of do-
mains caused by aberrant gene predictions [44].
Systematic large-scale searches to identify novel domains
within the completely sequenced genomes of eukaryotes
have not been widespread. Hutter and colleagues searched
for novel extracellular modules in the predicted set of Caeno-
rhabditis elegans proteins, and identi¢ed 20 apparently nem-
atode speci¢c motifs [25]. We have recently analyzed all sta-
tistically signi¢cant repeats within proteins occurring in the
Drosophila genome, leading to the characterization of 41 re-
peat or domain families [43]. It is likely that domain-based
annotation of eukaryotic genomes would greatly bene¢t from
more such systematic studies.
As long as new sequence is added to databases, it will be
necessary to re-visit the annotation of sequences, even within
complete genomes, to see if additional domains can be de-
tected by new comparisons. Understanding the domain struc-
ture of proteins within completed genomes is vital for a better
understanding of the evolutionary forces and emerging func-
tions shaping genomes.
6. Towards complete coverage of domains
At ¢rst sight, the obvious goal of computational domain
identi¢cation might be to ensure that every residue of every
sequence is annotated as falling within some domain family.
The current release of PFAM (6.6), probably the most com-
prehensive individual database, contains 3071 models covering
70% of sequences, but only 50% of residues from the sequence
database that it is constructed from (Alex Bateman, pers.
comm.). Coverage of completed genomes is lower than cover-
age of non-redundant sequence databases as the contents of
non-redundant protein sequence databases are biased towards
well-studied proteins [26] (typically around 30% of residues
from eukaryotic genomes are currently assigned to PFAM
families). The true coverage of globular protein domains
may be higher than these numbers suggest. Analysis of the
same dataset used to construct PFAM 6.6 shows that 2% of
residues are predicted to be coiled-coil regions, and 7% low
complexity, with biased amino acid composition. Complete
genomes show a similar proportion of non-globular sequence,
suggesting that a more realistic target for domain coverage is
closer to 90% of residues than 100%.
The fraction of residues that, on the basis of sequence sim-
ilarity, can be assigned to the structure-based superfamilies of
scop [27] ranges from 29% in C. elegans to 56% in the para-
sitic bacteria Buchnera [28] (see http://stash.mrc-lmb.cam.
ac.uk/). As these numbers are comparable to those found
for sequence-based classi¢cations, and as the sequence- and
structure-based classi¢cations are partially non-overlapping
(i.e. not all sequence-based families have known structures,
and not all known structures are used in the construction of
sequenced-based families), this suggests that the overall level
of possible family-based annotation, if all sources are used, is
higher still.
In practice, the maximum realistically achievable level of
coverage by sequence-based classi¢cations is likely to be lower
than those based on structures. Sequences linking domains
together, or found at the N- and C-termini of proteins, are
not necessarily distinct globular domains themselves, but can
form linker regions speci¢c to particular domain combina-
tions. Sequence boundaries of domains are not necessarily
well conserved; the conserved core modelled in a sequence
alignment may not represent the full extent of a domain in
any given case, again lowering the overall residue coverage.
The lack of conservation of these two types of sequence (i.e.
domain linker regions and family-speci¢c domain extensions)
makes their inclusion in sequence-based classi¢cations prob-
lematic. It is di⁄cult to estimate the overall percentage of
sequence that is likely to be found in such regions and so
get an estimate of the target level of residue coverage of se-
quence-based classi¢cation. Deciding between what is linker
and what is domain is only possible on the basis of 3D struc-
ture, but clearly 3D structures represent a very biased sample
of all protein sequence, and have been chosen speci¢cally for
their domain-like properties. One might expect regions of
long, unstructured linker between domains to be fairly un-
common in nature ^ long linker regions would allow relatively
independent movement of the domains they linked, in which
case there would be few obvious reasons for the two domains
to be in the same polypeptide in the ¢rst place (simultaneously
binding distant sites on DNA or RNA is a possibility, for
instance).
7. The values of structures
The interplay between sequence-based analysis of domain
families, and the study of 3D structure is great. Protein do-
mains identi¢ed by sequence have long been targeted for fur-
ther structural analyses, and sequence-based identi¢cation of
conserved domains and their boundaries is often a prelude to
structure determination, and hence better understanding of
function (Fig. 2). With the advent of structural genomics ini-
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tiatives aiming to determine the structures of representatives
of all proteins, accurate and thorough sequence-based domain
identi¢cation will assume a new signi¢cance, if overall work-
load is to be minimized [26].
At the same time, structure determination highlights the
limits of sequence-based analysis. The multi-domain nature
of many proteins is only recognized after the structures have
been solved. For instance, structure determination of the the
FERM domain (band 4.1), revealed that the domain was in
fact constituted from three distinct structural domains, all
with similarity to other independently occurring domains
[29]. 3D structure is also crucial for revealing how domains
interact, either in the same polypeptide chain, or in complexes.
The 3D structure of src tyrosine kinase, for instance, reveals
how the SH3, SH2 and tyrosine kinase domains interact via
the tail of the tyrosine kinase to inhibit activity [30].
As well as the intrinsic value of structures for rationalizing
the function of protein domains, they provide a deeper frame-
work within which to understand domain evolution. Compar-
ison of structures can reveal evolutionary relationships be-
tween domains when no signi¢cant sequence similarity is
detectable. Thus, for examples, the ephrin ectodomain was
recently shown to be a distant homolog of plant phytocyanins
[31] and the structure of the cytokine interleukin-17 showed it
to be a distant homolog of the cystine-knot family [32]. Not
all such identi¢cations lead to insights into function, however,
the G2 domain of nidogen shows clear similarity to green
£uorescent protein, but there do not appear to be any imme-
diate functional consequences of this relationship [33].
Although structural, as opposed to sequence evidence is
usually the arbiter in the interpretation of domain evolution,
an interesting recent example has shown the opposite. The
KH domain, initially identi¢ed on the basis of sequence pro-
¢les, has recently been demonstrated to adopt two di¡erent
3D folds [34]. In general, such results are likely to be unusual,
but they have profound consequences for our views of protein
evolution [35].
In general, structural data provide a rich complement to
sequence analyses, providing information on the evolutionary
history of domains, the interactions between them, and de-
tailed information about which residues are responsible for
function. Providing better links between the broad brush,
but high coverage, of sequence analysis and the ¢ne-grained
detail that structure provides will be to the bene¢t of both
approaches.
8. Future directions
The ultimate reason for delineating protein domain families
is to better understand protein function. By isolating regions
that are conserved in di¡erent proteins, we identify common
elements that can be valuable for further study. The PX do-
main, for example, was ¢rst described in 1996 [36], but only in
the past few months has its function been better characterized
(see [37] for a brief review). The basic premise that conserved
domains are likely to be functionally important leads to the
corollary that less taxonomically widespread will not have
such universally important functions. On the other hand, do-
mains found in limited taxonomic ranges are likely to be no
less interesting in as much as they will be responsible for
organism-speci¢c biology. Given this, it is reasonable to as-
sume that continued e¡orts will eventually lead to the delin-
eation of all the conserved protein domains and families with-
in completed genomes.
Beyond the identi¢cation of members of a particular do-
main family, much work remains in developing methods that
can help make more detailed predictions about the di¡erences
in function between family members. Initial function assign-
ments for a domain family are often made based on the
known functions of a protein, and the functions of other
domains that co-occur with the new domain. At a simple
level, for example, domains can be predicted to have a nuclear
localization based on co-occurrence with other domains
known to be found in proteins localized to the nucleus ([44]
and Fig. 3). Use of this kind of contextual information could
be formalized and expanded to make more valuable detailed
predictions that need apply only to speci¢c members of the
family. Another promising approach is the comparison of
patterns of residue conservation across di¡erent subfamilies
within a multiple sequence alignment [38], a procedure that
is greatly facilitated by reference to 3D structure [39,40]. De-
velopment of these and similar techniques should also bene¢t
from the current focus on large-scale studies of protein^pro-
tein interactions [41,42]. Integrating such studies within the
hierarchies provided by the results of structural genomics,
structural analysis and genome sequencing will provide a
rich framework for understanding the diversity and evolution
of protein and domain function.
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